全エクソームシーケンスの市場規模、シェア、成長分析：製品別、技術別、ワークフロー別、用途別、最終用途別、地域別 - 産業予測 2025～2032年

全エクソームシーケンスの世界市場規模は2023年に4億9,688万米ドルとなり、2024年の5億8,334万米ドルから2032年には21億506万米ドルに成長し、予測期間（2025年～2032年）のCAGRは17.4％で成長する見通しです。

全エクソームシーケンス市場は、遺伝性疾患や慢性疾患の早期かつ正確な検出を促進する技術の進歩によって力強い成長を遂げています。調査や診断における新たな用途は、コストの低下と相まって、個別化医療ソリューションへの需要を大幅に高めています。医療専門家は現在、全エクソームシーケンスを活用して遺伝的変異を特定し、個々の患者に合わせた治療を行い、臨床転帰を向上させています。中国のヘルスケア・プロバイダーとBGI Genomics社との提携のようなコラボレーションは、こうしたサービスの利用しやすさが増していることを裏付けています。特筆すべきは、NateraのFDA指定画期的デバイスSignateraのような革新的技術が、がん診断とモニタリングにおけるエクソームシーケンスの変革の可能性を例証していることです。個別化医療が牽引役となるにつれ、市場は新たな診断法や技術によって継続的に拡大する態勢が整っています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

全エクソームシーケンス市場規模：製品別

• 市場概要
• 機器
• 消耗品
• システム
• キット
• サービス

全エクソームシーケンス市場規模：技術別

• 市場概要
• 合成によるシーケンス
• イオン半導体シーケンス
• その他

全エクソームシーケンス市場規模：ワークフロー別

• 市場概要
• プレシーケンス
• シーケンス
• データ分析

全エクソームシーケンス市場規模：用途別

• 市場概要
• 臨床診断
• 医薬品の発見と開発
• パーソナライズ医療
• 農業と動物調査
• その他

全エクソームシーケンス市場規模：最終用途別

• 市場概要
• 学術研究機関
• 病院・クリニック
• 製薬・バイオテクノロジー企業
• その他

全エクソームシーケンス市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Illumina, Inc.（USA）
• Thermo Fisher Scientific, Inc.（USA）
• Agilent Technologies, Inc.（USA）
• Pacific Biosciences of California, Inc.（PacBio）（USA）
• Oxford Nanopore Technologies plc.（UK）
• BGI Genomics Co., Ltd.（China）
• Eurofins Scientific SE（Luxembourg）
• Bio-Rad Laboratories, Inc.（USA）
• Novogene Co., Ltd.（China）
• Azenta, Inc.（formerly GENEWIZ）（USA）
• CD Genomics（USA）
• Psomagen, Inc.（South Korea）
• F. Hoffmann-La Roche AG（Switzerland）
• 10x Genomics, Inc.（USA）
• Bionano Genomics, Inc.（USA）
• Dante Labs（Italy）
• MGI Tech Co., Ltd.（China）
• GeneDx Holdings Corp.（USA）
• Helix OpCo, LLC（USA）

結論と推奨事項

Global Whole Exome Sequencing Market size was valued at USD 496.88 million in 2023 and is poised to grow from USD 583.34 million in 2024 to USD 2105.06 million by 2032, growing at a CAGR of 17.4% during the forecast period (2025-2032).

The market for whole exome sequencing is experiencing robust growth driven by advancements in technology that facilitate early and accurate detection of genetic and chronic diseases. New applications in research and diagnostics, coupled with decreasing costs, have significantly increased demand for personalized medical solutions. Medical professionals now leverage whole exome sequencing to identify genetic variations and tailor treatments to individual patients, enhancing clinical outcomes. Collaborations, such as the partnership between a Chinese healthcare provider and BGI Genomics, underscore the rising accessibility of these services. Notably, innovations like Natera's FDA-designated breakthrough device, Signatera, exemplify the transformative potential of exome sequencing in cancer diagnosis and monitoring. As personalized medicine gains traction, the market is poised for continued expansion with emerging diagnostics and technologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Whole Exome Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Whole Exome Sequencing Market Segmental Analysis

Global Whole Exome Sequencing Market is segmented by Product, Technology, Workflow, Application, End-use and region. Based on Product, the market is segmented into Instruments, Consumables, System, Kits and Services. Based on Technology, the market is segmented into Sequencing by Synthesis, ION Semiconductor Sequencing and Others. Based on Workflow, the market is segmented into Pre-Sequencing, Sequencing and Data Analysis. Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, Agriculture and Animal Research and Others. Based on End-use, the market is segmented into Academic And Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Whole Exome Sequencing Market

A key factor contributing to the expansion of the global whole exome sequencing market is the rising demand for personalized medicine. By analyzing an individual's entire exome, healthcare providers can tailor treatment plans that align with the patient's specific genetic profile and risk of disease. This bespoke approach not only enhances the efficacy of therapies but also promotes better patient outcomes. The continued advancements in sequencing technologies and data analysis capabilities have made whole exome sequencing increasingly accessible and cost-effective, thus encouraging its implementation in clinical environments. As the emphasis on personalized healthcare continues to grow, so does the demand for whole exome sequencing, shaping the future landscape of medical treatment.

Restraints in the Global Whole Exome Sequencing Market

A notable constraint impacting the global whole exome sequencing market is the challenges tied to data complexity and interpretation. The considerable volume of genomic data produced presents significant difficulties in analysis, necessitating extensive expertise and time. Ensuring that the results are both accurate and reliable is essential for making sound medical decisions. The reliance on advanced bioinformatics tools and qualified personnel for effective data handling and interpretation limits the broader adoption of whole exome sequencing. Consequently, this factor restricts its accessibility and feasibility in various healthcare environments, hindering the implementation of this innovative technology.

Market Trends of the Global Whole Exome Sequencing Market

The Global Whole Exome Sequencing market is witnessing a significant trend driven by the integration of artificial intelligence (AI) and machine learning (ML) algorithms into data analysis and interpretation processes. This innovative approach is transforming how vast amounts of genomic data generated through whole exome sequencing are processed, enabling more efficient identification of genetic variations and disease associations. By automating data handling, AI and ML improve accuracy and efficiency in genomic analysis, thus facilitating faster, precise diagnoses and personalized treatment strategies. As these technologies continue to evolve, they are set to revolutionize genomic medicine, underscoring their critical role in shaping the future of healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Whole Exome Sequencing Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Consumables
• System
• Kits
• Services

Global Whole Exome Sequencing Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Sequencing by Synthesis
• ION Semiconductor Sequencing
• Others

Global Whole Exome Sequencing Market Size by Workflow & CAGR (2025-2032)

• Market Overview
• Pre-Sequencing
• Sequencing
• Data Analysis

Global Whole Exome Sequencing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Clinical Diagnostics
• Drug Discovery & Development
• Personalized Medicines
• Agriculture and Animal Research
• Others

Global Whole Exome Sequencing Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Academic And Research Institutes
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Others

Global Whole Exome Sequencing Market Size & CAGR (2025-2032)

• North America (Product, Technology, Workflow, Application, End-use)
  • US
  • Canada
• Europe (Product, Technology, Workflow, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Workflow, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Workflow, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Workflow, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc. (PacBio) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novogene Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Azenta, Inc. (formerly GENEWIZ) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CD Genomics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Psomagen, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionano Genomics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dante Labs (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MGI Tech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneDx Holdings Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helix OpCo, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations